Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHASAP: Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy
2024-516461-36-00Phase 3Authorised
- Sponsor
- Centre Hospitalier Intercommunal de Créteil
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in preeclampsia, intrauterine growth restriction (IUGR) and maternal hypertension (HDP) comparing Acard (acetylsalicylic acid) with Placebo (2 arms). Primary endpoint: Composite maternal-fetal morbidity-mortality outcome. Planned start Oct 2024; status: authorised.
02
Drugs
Cartia
03
Conditions
preeclampsiaintrauterine growth restriction (IUGR)maternal hypertension (HDP)
Beyond the preview
Go deeper on 2024-516461-36-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516461-36-00.